Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Granulocyte Colony-stimulating Factor (G-CSF) Mobilized”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableUnknownNCT02184897
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Asan Medical Center 24
Not applicableLooking for participantsNCT00001529
What this trial is testing

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Who this might be right for
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI) 500
Testing effectiveness (Phase 2)Ended earlyNCT01182675
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 7
Testing effectiveness (Phase 2)Study completedNCT02931071
What this trial is testing

Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1

Who this might be right for
Fanconi Anemia
Hospital Universitari Vall d'Hebron Research Institute 13
Testing effectiveness (Phase 2)Study completedNCT00008268
What this trial is testing

Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03317899
What this trial is testing

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaPlasma Cell Myeloma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 77
Very early researchUnknownNCT05970185
What this trial is testing

The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization

Who this might be right for
Granulocyte Colony-Stimulating Factor
Zhongnan Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT05421416
What this trial is testing

Loratadine for the Prevention of G-CSF-related Bone Pain

Who this might be right for
Stem Cell Transplant Complications
AHS Cancer Control Alberta 78
Large-scale testing (Phase 3)Ended earlyNCT01301963
What this trial is testing

Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide

Who this might be right for
Refractory Multiple Myeloma
Case Comprehensive Cancer Center 9
Not applicableStudy completedNCT00115128
What this trial is testing

Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors

Who this might be right for
Normal PBPC Donors
Amgen 309
Not applicableLooking for participantsNCT07186179
What this trial is testing

Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)

Who this might be right for
Diamond Blackfan Anemia
Northwell Health 10
Early research (Phase 1)Study completedNCT00233961
What this trial is testing

G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission

Who this might be right for
Leukemia
Herbert Irving Comprehensive Cancer Center 20
Not applicableEnded earlyNCT01076270
What this trial is testing

Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+80 more
Fred Hutchinson Cancer Center 1
Very early researchLooking for participantsNCT04211259
What this trial is testing

Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization

Who this might be right for
Plasma Cell Myeloma
Rutgers, The State University of New Jersey 70
Testing effectiveness (Phase 2)UnknownNCT00526734
What this trial is testing

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Erasme University Hospital 100
Not applicableStudy completedNCT01901458
What this trial is testing

Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®

Who this might be right for
Healthy Allogeneic DonorsGranulocyte Colony-stimulating Factor (G-CSF) Mobilized
Heinrich-Heine University, Duesseldorf 50
Testing effectiveness (Phase 2)Study completedNCT00082329
What this trial is testing

G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers

Who this might be right for
Healthy
National Heart, Lung, and Blood Institute (NHLBI) 9
Testing effectiveness (Phase 2)Study completedNCT02098109
What this trial is testing

Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaLymphoma, Non-Hodgkin
Washington University School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT02221479
What this trial is testing

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genzyme, a Sanofi Company 14
Post-approval studies (Phase 4)Study completedNCT00126100
What this trial is testing

Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)

Who this might be right for
Myocardial Infarction
Deutsches Herzzentrum Muenchen 114
Next Page